Autoimmune haemolytic anaemia (AIHA) develops when the immune system mistakenly targets and destroys red blood cells, leading to a shortage of these vital components. This disruption in the delicate balance of red cell turnover results in a reduced capacity to transport oxygen, triggering a cascade of symptoms that can significantly impact daily life. Understanding the triggers and mechanisms behind this condition is essential for accurate diagnosis and effective management, as the underlying cause is not always immediately apparent.
Primary Autoimmune Haemolytic Anaemia
In many instances, the condition presents without a clear preceding event, classified as primary autoimmune haemolytic anaemia. Here, the immune system generates antibodies—proteins designed to fight infection—that erroneously mark the body's own red blood cells as foreign invaders. This misguided attack causes the cells to rupture prematurely, primarily within the spleen. The exact reason why the immune system loses tolerance to its own red blood cells remains a complex area of ongoing research, involving a potential combination of genetic susceptibility and environmental influences that disrupt immune regulation.
Secondary Autoimmune Haemolytic Anaemia
Underlying Medical Conditions
Secondary AIHA occurs when the production of these harmful antibodies is a direct consequence of another identifiable disorder. Systemic autoimmune diseases are frequent culprits, as the body’s widespread inflammatory response can blur the lines between self and non-self. Conditions such as systemic lupus erythematosus and rheumatoid arthritis often feature this type of anaemia as a complicating factor, requiring management of both the primary illness and the resulting blood disorder.
Malignancies, particularly lymphoproliferative disorders like chronic lymphocytic leukaemia (CLL), can stimulate the immune system to produce abnormal antibodies that target red blood cells.
Infections, ranging from common viral illnesses like Mycoplasma pneumoniae and Epstein-Barr virus to more severe bacterial infections, can sometimes trigger a temporary form of AIHA.
Medication-Induced Causes
Another significant pathway to secondary AIHA is drug-induced immune activation. Certain medications can alter the surface of red blood cells or provoke an immune response that generates antibodies against them. This reaction typically subsides once the medication is discontinued, highlighting the importance of a thorough medication review during diagnosis. Common offenders include certain antibiotics and blood pressure medications.
Understanding the Immune System's Error
Regardless of the initial trigger, the biological consequence is consistent: the immune system produces antibodies that bind to red blood cells. These tagged cells are then recognized and destroyed by the spleen and liver, organs designed to filter out old or damaged cells. When this destruction occurs at an accelerated rate, the bone marrow struggles to compensate by producing new cells fast enough, leading to the clinical presentation of anaemia. The specific type of antibody involved—warm or cold—dictates the temperature at which the immune attack is most active, influencing the severity and treatment approach.
Risk Factors and Identification
While AIHA can affect individuals of any age, certain groups are statistically more vulnerable. Conditions that compromise immune function or create chronic inflammation increase the likelihood of the immune system turning on the body's own blood cells. Identifying these risk factors is a critical step in the diagnostic journey, helping clinicians to narrow down potential causes and tailor the investigative process.
